Cumberland Pharmaceuticals Inc
$7.32
Market Cap
$109.68M
Shares Outstanding
15.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 11, 2009
Round Lot
100
Locale
US
Day Open
$7.19
Day High
$7.34
Day Low
$7.02
Volume
27.7K
VWAP
$7.26
Prev Close
$7.19
Transactions
--
Acc. Volume
--
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Cumberland Pharmaceuticals Inc (CPIX) closed the 2026-09-18 session at $7.32, up 1.81% versus the previous close (+0.13). The stock opened at $7.19 and traded between $7.02 and $7.34 during that session. Session trading volume was 28K shares. The volume-weighted average price (VWAP) is $7.26.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Cumberland Pharmaceuticals Inc has a market capitalization of $109.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CPIX is listed on the XNAS exchange. The company employs approximately 93 people. Cumberland Pharmaceuticals Inc is headquartered in NASHVILLE,, TN. The recorded listing date is 2009-08-11.
On this page you can find market CPIX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.